Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Symbol
CMPX
Shares outstanding
137,716,408 shares
Disclosed Ownership
13,496,208 shares
Ownership
9.8%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:15:07 UTC
Date of event
30 Jun 2025
Previous filing
15 May 2025
Next filing
14 Nov 2025

Sponsored

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 9.8% ownership in Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX) on 30 Jun 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX).
  • Disclosed ownership: 9.8%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 15 May 2025.
  • Current filing was accepted on 14 Aug 2025, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 9.8% 13,496,208 0 13,496,208 /s/ Kevin Tang Manager
KEVIN TANG 9.8% 13,496,208 0 13,496,208 /s/ Kevin Tang Self
TANG CAPITAL PARTNERS, LP 4.9% 6,765,438 0 6,765,438 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP 3.9% 5,397,770 0 5,397,770 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 0.7% 999,750 0 999,750 /s/ Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0.3% 333,250 0 333,250 /s/ Kevin Tang Chief Executive Officer